1.
Product Overview
2.
Research Methodology
3. Impact of COVID-19 on Global Companion Diagnostic Market
4. Executive Summary
5. Voice of Customer
5.1. Factors Driving the Companion
Diagnostic Market
5.2. Brand Awareness
5.3. Customer
Satisfaction Analysis
6. Global Companion
Diagnostic Market Outlook
6.1.
Market Size & Forecast
6.1.1. By Value
6.2.
Market Share & Forecast
6.2.1. By Products and
Services (Kits and Reagents, Assays, Software and Services)
6.2.2. By Technology
(Polymerase Chain Reaction (PCR), Next-Generation sequencing (NGS), In-Situ
Hybridization, Immunohistochemistry and Others)
6.2.3. By Disease
Indication (Oncology, Neurology, Cardiology, Infectious Diseases and Others)
6.2.4. By End-User (Pharmaceutical
& Biotechnology Companies, Research Laboratories, Contract Research Organization
and Others)
6.2.5. By Application
(In-Vitro Diagnostics, Drug Discovery and Others)
6.2.6. By Company (2020)
6.2.7. By Region
6.3. Product Market Map
7. North America Companion
Diagnostic Market Outlook
7.1.
Market Size & Forecast
7.1.1. By Value
7.2.
Market Share & Forecast
7.2.1. By Products and
Services
7.2.2. By Technology
7.2.3. By Disease
Indication
7.2.4. By End User
7.2.5. By Application
7.2.6. By Country
7.3.
North America: Country Analysis
7.3.1. United States Companion
Diagnostic Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By Products and Services
7.3.1.2.2.
By Technology
7.3.1.2.3.
By Disease Indication
7.3.1.2.4.
By End User
7.3.1.2.5.
By Application
7.3.2. Canada Companion
Diagnostic Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By Products and Services
7.3.2.2.2.
By Technology
7.3.2.2.3.
By Disease Indication
7.3.2.2.4.
By End User
7.3.2.2.5.
By Application
7.3.3. Mexico Companion
Diagnostic Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecast
7.3.3.2.1.
By Products and Services
7.3.3.2.2.
By Technology
7.3.3.2.3.
By Disease Indication
7.3.3.2.4.
By End User
7.3.3.2.5.
By Application
8. Europe Companion
Diagnostic Market Outlook
8.1.
Market Size & Forecast
8.1.1. By Value
8.2.
Market Share & Forecast
8.2.1. By Products and
Services
8.2.2. By Technology
8.2.3. By Disease
Indication
8.2.4. By End User
8.2.5. By Application
8.2.6. By Country
8.3.
Europe: Country Analysis
8.3.1. Germany Companion
Diagnostic Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Products and Services
8.3.1.2.2.
By Technology
8.3.1.2.3.
By Disease Indication
8.3.1.2.4.
By End User
8.3.1.2.5.
By Application
8.3.2. United Kingdom
Companion Diagnostic Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Products and Services
8.3.2.2.2.
By Technology
8.3.2.2.3.
By Disease Indication
8.3.2.2.4.
By End User
8.3.2.2.5.
By Application
8.3.3. France Companion
Diagnostic Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Products and Services
8.3.3.2.2.
By Technology
8.3.3.2.3.
By Disease Indication
8.3.3.2.4.
By End User
8.3.3.2.5.
By Application
8.3.4. Italy Companion
Diagnostic Market Outlook
8.3.4.1.
Market Size & Forecast
8.3.4.1.1.
By Value
8.3.4.2.
Market Share & Forecast
8.3.4.2.1.
By Products and Services
8.3.4.2.2.
By Technology
8.3.4.2.3.
By Disease Indication
8.3.4.2.4.
By End User
8.3.4.2.5.
By Application
8.3.5. Spain Companion
Diagnostic Market Outlook
8.3.5.1.
Market Size & Forecast
8.3.5.1.1.
By Value
8.3.5.2.
Market Share & Forecast
8.3.5.2.1.
By Products and Services
8.3.5.2.2.
By Technology
8.3.5.2.3.
By Disease Indication
8.3.5.2.4.
By End User
8.3.5.2.5.
By Application
9. Asia-Pacific Companion
Diagnostic Market Outlook
9.1.
Market Size & Forecast
9.1.1. By Value
9.2.
Market Share & Forecast
9.2.1. By Products and
Services
9.2.2. By Technology
9.2.3. By Disease
Indication
9.2.4. By End User
9.2.5. By Application
9.2.6. By Country
9.3.
Asia-Pacific: Country Analysis
9.3.1. China Companion
Diagnostic Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Products and Services
9.3.1.2.2.
By Technology
9.3.1.2.3.
By Disease Indication
9.3.1.2.4.
By End User
9.3.1.2.5.
By Application
9.3.2. Japan Companion
Diagnostic Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Products and Services
9.3.2.2.2.
By Technology
9.3.2.2.3.
By Disease Indication
9.3.2.2.4.
By End User
9.3.2.2.5.
By Application
9.3.3. India Companion
Diagnostic Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Products and Services
9.3.3.2.2.
By Technology
9.3.3.2.3.
By Disease Indication
9.3.3.2.4.
By End User
9.3.3.2.5.
By Application
9.3.4. South Korea Companion
Diagnostic Market Outlook
9.3.4.1.
Market Size & Forecast
9.3.4.1.1.
By Value
9.3.4.2.
Market Share & Forecast
9.3.4.2.1.
By Products and Services
9.3.4.2.2.
By Technology
9.3.4.2.3.
By Disease Indication
9.3.4.2.4.
By End User
9.3.4.2.5.
By Application
9.3.5. Australia Companion
Diagnostic Market Outlook
9.3.5.1.
Market Size & Forecast
9.3.5.1.1.
By Value
9.3.5.2.
Market Share & Forecast
9.3.5.2.1.
By Products and Services
9.3.5.2.2.
By Technology
9.3.5.2.3.
By Disease Indication
9.3.5.2.4.
By End User
9.3.5.2.5.
By Application
9.3.6. Singapore Companion
Diagnostic Market Outlook
9.3.6.1.
Market Size & Forecast
9.3.6.1.1.
By Value
9.3.6.2.
Market Share & Forecast
9.3.6.2.1.
By Products and Services
9.3.6.2.2.
By Technology
9.3.6.2.3.
By Disease Indication
9.3.6.2.4.
By End User
9.3.6.2.5.
By Application
10. South America Companion
Diagnostic Market Outlook
10.1.
Market Size & Forecast
10.1.1. By Value
10.2.
Market Share & Forecast
10.2.1. By Products and
Services
10.2.2. By Technology
10.2.3. By Disease
Indication
10.2.4. By End User
10.2.5. By Application
10.2.6. By Country
10.3.
South America: Country Analysis
10.3.1. Brazil Companion
Diagnostic Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1.
By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1.
By Products and Services
10.3.1.2.2.
By Technology
10.3.1.2.3.
By Disease Indication
10.3.1.2.4.
By End User
10.3.1.2.5.
By Application
10.3.2. Argentina Companion
Diagnostic Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1.
By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1.
By Products and Services
10.3.2.2.2.
By Technology
10.3.2.2.3.
By Disease Indication
10.3.2.2.4.
By End User
10.3.2.2.5.
By Application
10.3.3. Colombia Companion
Diagnostic Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1.
By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1.
By Products and Services
10.3.3.2.2.
By Technology
10.3.3.2.3.
By Disease Indication
10.3.3.2.4.
By End User
10.3.3.2.5.
By Application
11. Middle East and
Africa Companion Diagnostic Market Outlook
11.1.
Market Size & Forecast
11.1.1. By Value
11.2.
Market Share & Forecast
11.2.1. By Products and
Services
11.2.2. By Technology
11.2.3. By Disease
Indication
11.2.4. By End User
11.2.5. By Application
11.2.6. By Country
11.3.
MEA: Country Analysis
11.3.1. South Africa
Companion Diagnostic Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1.
By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1.
By Products and Services
11.3.1.2.2.
By Technology
11.3.1.2.3.
By Disease Indication
11.3.1.2.4.
By End User
11.3.1.2.5.
By Application
11.3.2. Saudi Arabia Companion
Diagnostic Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1.
By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1.
By Products and Services
11.3.2.2.2.
By Technology
11.3.2.2.3.
By Disease Indication
11.3.2.2.4.
By End User
11.3.2.2.5.
By Application
11.3.3. UAE Companion
Diagnostic Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1.
By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1.
By Products and Services
11.3.3.2.2.
By Technology
11.3.3.2.3.
By Disease Indication
11.3.3.2.4.
By End User
11.3.3.2.5.
By Application
12.
Market Dynamics
12.1.
Drivers
12.2.
Challenges
13.
Market Trends & Developments
14.
Competitive Landscape
14.1.
Competition Outlook
14.2.
Players Profiled (Leading Companies)
14.2.1.
Thermo Fisher Scientific Inc.
14.2.2.
Illumina Inc.
14.2.3.
Bayer AG
14.2.4.
Quest Diagnostics Inc.
14.2.5.
Danaher Corporation
14.2.6.
Qiagen NV
14.2.7.
Seimens Healthineers AG
14.2.8.
F. Hoffmann-La Roche AG
14.2.9.
Agilent Technologies Inc.
14.2.10.
Abbott Laboratories Inc.
14.2.11.
DiaSorin SpA (Luminex Corporation)
14.2.12.
Icon Plc (MolecularMD Corporation)
14.2.13.
Myriad Genetics Inc.
14.2.14.
Biogenex Laboratories Inc.
14.2.15.
bioMérieux SA
15. Strategic Recommendations
16. About Us & Disclaimer
In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com